A multinational pharmaceutical company with operations in several Latin American countries asked Leaderlix for KOL speaker training to solve a problem that science was not solving on its own. Its business unit in one therapeutic area sold a product with a dosing regimen different from the one that dominated the local market.

The safety and efficacy evidence was solid, backed by more than a decade of international clinical experience. Even so, the local market held on to an entrenched belief about toxicity risks that the data did not support.
The starting point
That perception of risk did not appear by itself. Competitors had established it effectively, and it worked as both a commercial and a scientific barrier.
The specialists who advocated for the product faced another problem when they presented evidence at congresses and large forums. Audiences saw them as spokespeople for commercial interests, and that undermined their credibility before they finished speaking. In those settings, attendees did not raise their real doubts. The conversation stayed on the surface and the debate did not move forward.
The company had a precedent in another market in the region. There, what settled the debate was a combination of an institutional consensus validated by medical societies and continuing medical education in small groups. More publications and more auditorium presentations had not been enough. The intimate format, where real conversation is possible, did work.
The goal was to replicate that logic in the local market, with thought leaders able to communicate with structure, credibility, and empathy. Scientific expertise alone was not enough. The specialists needed concrete tools to:

- Present evidence clearly to audiences with different levels of receptiveness.
- Handle objections without becoming defensive.
- Adapt their communication to small settings, where genuine exchange happens.
- Hold their position on safety, efficacy, and convenience in front of their own peers.
What we did
Leaderlix designed a scientific communication development program for that group of medical specialists, combining speaker training and coaching.
Results
Participants moved from an initial stance of skepticism to one of real openness. Feedback on the methodology was consistently positive, and the case analysis identified the factors behind that result and the conditions that made it possible to move toward a medical consensus.
The full case study describes the program structure, the methodology, the results, and the conditions that made the change possible.
Why it matters to you
If you work in medical communication, thought leader development, or strategies to change clinical practice, this case offers a concrete framework for stepping in when the evidence exists but is not enough to shift an entrenched belief. You can see how we run these programs in our communication coaching for medical thought leaders.
